DDW 2023 is the place to learn about TissueCypher and Barrett’s esophagus risk stratification
New data from five unique TissueCypher studies will be presented at Digestive Disease Week 2023 in Chicago.
If you’re planning to attend DDW, request some time with our team to discuss how this new prognostic test can improve management of Barrett’s esophagus patients. The Castle Biosciences team will be at Booth 4132 near the show management booth in the Exhibit Hall.
John Lipham, MD
Professor of Surgery
Keck Medicine of USC
Harshit Khara, MD, FACG, FASGE
Director of Endoscopy
Geisinger Medical Center
Raman Muthusamy, MD, MAS
Medical Director of Endoscopy
UCLA Health
Research Forum
AGA Risk Stratification in Barrett’s Esophagus — Are We There Yet?
May 6 • 2-3:30 p.m. CT
TissueCypher Presentation
A Tissue Systems Pathology Test Outperforms Standard Clinicopathologic Variables in Predicting Progression in Patients with Barrett’s Esophagus
Presenter: Jon Davison, MD, pathologist at UPMC
Time: 2:20-2:45 p.m. CT
Topic Forum
ASGE Advances in Imaging and Diagnostics in Esophageal Neoplasia in 2023
May 8 • 8-9:30 a.m. CT
TissueCypher Presentation
A Tissue Systems Pathology Test Enables Risk-Aligned Management of Patients with Non-Dysplastic Barrett’s Esophagus: A Case Series at an Expert Foregut Surgery Center
Presenter: Paul Wisniowski, MD
Time: 8:52-9 a.m. CT
AGA Barrett’s Esophagus – Epidemiology, Risk Factors, Screening and Surveillance, Treatment and Clinical Outcomes
[Tu1270]
A Tissue Systems Pathology Test Enables Standardized, Risk-Aligned Management of Patients with Barrett’s Esophagus
[Tu1271]
A Tissue Systems Pathology Test Has Significant Clinical Utility to Standardize Management Leading to Improved Health Outcomes for Barrett’s Esophagus Patients with Low-Grade Dysplasia
[Tu1272]
A Tissue Systems Pathology Test Objectively Risk-Stratifies Patients with Barrett’s Esophagus: Results From a Multicenter U.S. Clinical Experience
Spatialomics delivered to the clinic for improved health outcomes in Barrett’s esophagus
Presenter: Rebecca Critchley-Thorne, PhD
Time: May 8, 10 a.m. CT; May 9, 9:30 a.m. and 12:15 p.m. CT
Treatment algorithm for non-dysplastic Barrett’s esophagus
Presenters: Jon Lipham, MD, and Jay Morris, PhD
Time: May 6, 11:30 a.m. - 12 p.m. CT
Obstacles to cancer prevention in Barrett’s esophagus
Presenters: Stuart Spechler, MD, and Jay Morris, PhD
Time: May 7, 10-10:30 a.m. CT
Clinical utility of TissueCypher at Geisinger Health
Presenters: Harshit Khara, MD, and Jay Morris, PhD
Time: May 9, 2:45-3:15 p.m. CT
